| dc.creator | Shantsila, Eduard | |
| dc.creator | Lip, Gregory YH | |
| dc.date.accessioned | 2021-04-15T17:36:39Z | |
| dc.date.accessioned | 2022-09-23T18:15:37Z | |
| dc.date.available | 2021-04-15T17:36:39Z | |
| dc.date.available | 2022-09-23T18:15:37Z | |
| dc.date.created | 2021-04-15T17:36:39Z | |
| dc.identifier | 9783319040936 | |
| dc.identifier | https://directory.doabooks.org/handle/20.500.12854/35698 | |
| dc.identifier | http://hdl.handle.net/20.500.12010/18737 | |
| dc.identifier | 10.1007/978-3-319-25460-9 | |
| dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/3498085 | |
| dc.description.abstract | There are several disorders which carry an increased risk of
thrombosis, clots that interfere with normal circulation,
including: venous thromboembolism (VTE), comprising both
deep vein thrombosis (DVT) and pulmonary embolism (PE),
atrial fibrillation (AF), acute coronary syndromes (ACS),
valve disease and endocarditis, and conditions associated
with a raised risk of ischemic stroke. Due to this increased
risk, a number of thromboprophylactic medications target
the coagulation cascade. Effective anticoagulation can be
achieved by inhibiting different coagulation factors in the
coagulation cascade. | |
| dc.language | eng | |
| dc.publisher | Springer Nature | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.rights | Abierto (Texto Completo) | |
| dc.rights | https://creativecommons.org/licenses/by-nc/4.0/ | |
| dc.subject | Hematology | |
| dc.subject | Surgery | |
| dc.subject | Cardiology | |
| dc.title | Non-Vitamin K Antagonist Oral Anticoagulants: A Concise Guide | |
